Relationships between IGF-1 and IGFBP-1 and adiposity in obese African-American and latino adolescents

Obesity

Volumn 19, Issue 5, 2011, Pages 933-938

  Alderete, Tanya L ^a   Byrd Williams, Courtney E ^b   Toledo Corral, Claudia M ^a   Conti, David V ^a   Weigensberg, Marc J ^a   Goran, Michael I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ABDOMINAL SUBCUTANEOUS FAT; ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BODY COMPOSITION; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PROTEIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADOLESCENT; AFRICAN AMERICANS; BODY COMPOSITION; FEMALE; HISPANIC AMERICANS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; INTRA-ABDOMINAL FAT; LIVER; MALE; OBESITY; PUBERTY; UNITED STATES;

EID: 79955473111     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.211     Document Type: Article

References (33)

1. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003;195:127-137. (Pubitemid 36588961)
2. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704. (Pubitemid 38058173)
3. Cohen P. Serum insulin-like growth factor-1 levels and prostate cancer risk-interpreting the evidence. J Natl Cancer 1998; 90: 876-879. (Pubitemid 28304152)
4. Wolk A, Mantzoros CS, Andersson SO et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 1998;90:911-915. (Pubitemid 28304159)
5. Hankinson SE, Willett WC, Colditz GA et al. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998;351:1393-1396. (Pubitemid 28209997)
6. Vadgama J V, Wu Y, Datta G, Khan H, Chillar R. Plasma insulin-like growth factor-1 and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 1999;57:330-340.
7. Ma J, Pollak MN, Giovannucci E et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620-625. (Pubitemid 29194048)
8. Yu H, Spitz MR, Mistry J et al. Plasma levels of insulin-like growth factor-1 and lung cancer risk: a case-control analysis. J Natl Cancer Inst 1999;91:151-156. (Pubitemid 29042692)
9. Jogie-Brahim S, Feldman D, Oh Y. Unraveling IGFBP-3 actions in human disease. Endocr Rev 2009;10:2008-2028.
10. Nam SY, Lee EJ, Kim KR et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metabl Disord 1997;21:355-359. (Pubitemid 27190186)
11. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999;15:314-322. (Pubitemid 29535090)
12. Henderson KD, Goran MI, Kolonel LN, Henderson BE, Le Marchand L. Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2006;15:2298-2302. (Pubitemid 44877059)
13. Berrigan D, Potischman N, Dodd KW et al. Race/ethnic variation in serum levels of IGF-1 and IGFBP-3 in US adults. Growth Horm IGF Res 2009;19: 146-155.
14. Higgins PB, Fernández JR, Goran MI, Gower BA. Early ethnic difference in insulin-like growth factor-1 is associated with African genetic admixture. Pediatr Res 2005;58:850-854. (Pubitemid 41511053)
15. Toledo-Corral CM, Roberts CK, Shaibi GQ et al. Insulin-like growth factor-1 is inversely related to adiposity in overweight Latino children. J Pediatr Endocrinol Metab 2008;21:855-864.
16. Girgis R, Abrams SA, Castracane VD et al. Ethnic differences in androgens, IGF-1 and body fat in healthy prepubertal girls. J Pediatr Endocrinol Metab 2000;13:497-503. (Pubitemid 30253141)
17. Gapstur SM, Kopp P, Chiu BC et al. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-1 and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev 2004;13:2208-2216. (Pubitemid 40054319)
18. Slattery ML, Baumgartner KB, Byers T et al. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and nonHispanic white women. Cancer Causes Control 2005;16:1147-1157. (Pubitemid 46179498)
19. Juul A, Bang P, Hertel NT et al. Serum insulin-like growth factor-1 in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752. (Pubitemid 24083322)
20. Yanovski JA, Sovik KN, Nguyen TT, Sebring NG. Insulin-like growth factors and bone mineral density in African-American and White girls. J Pediatr 2000;137:826-832.
21. Garnett S P, Högler W, Blades B et al. Relation between hormones and body composition, including bone, in prepubertal children. Am J Clin Nutr 2004;80:966-972. (Pubitemid 41202099)
22. Ong K, Kratzsch J, Kiess W, Dunger D; ALSPAC Study Team. Circulating IGF-1 levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 2002;87: 1041-1044. (Pubitemid 36121062)
23. Goran MI. Ethnic-specific pathways to obesity-related disease: the Hispanic vs. African-American paradox. Obesity (Silver Spring) 2008;16:2561-2565.
24. DeLellis K, Rinaldi S, Kaaks RJ et al. Dietary and lifestyle correlates of plasma insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2004;13:1444-1451. (Pubitemid 39202310)
25. Davis JN, Kelly LA, Lane CJ et al. Randomized control trial to improve adiposity and insulin resistance in overweight Latino adolescents. Obesity 2009;10:1-7.
26. ADA. Type 2 diabetes in children and adolescents. Pediatrics 2000; 105: 671-680.
27. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
28. Ross R, Léger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992;72:787-795.
29. Max JB, Limburg PJ, Ogunseitan A et al. IGF-1, IGFBP-3, and IGF-1/ IGFBP-3 ratio: no association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev 2008;17:1832-1834.
30. Arany E, Afford S, Strain AJ et al. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. J Clin Endocrinol Metab 1994;79:1871-1876.
31. Volzke H, Nauck M, Rettig R et al. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population based sample. Eur J Endocrinol 2009;161:705-713.
32. Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 2005;41:426-429. (Pubitemid 41407604)
33. Grohmann M, Sabin M, Holly J et al. Characterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-alpha and IGF-1. J Lipid Res 2005;46:93-103. (Pubitemid 40066675)